Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.100
+0.030 (2.80%)
At close: May 22, 2026, 4:00 PM EDT
1.110
+0.010 (0.91%)
After-hours: May 22, 2026, 7:54 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $17.93 million as of May 22, 2026. Its market cap has decreased by -60.55% in one year.
Market Cap
17.93M
Enterprise Value
60.81K
1-Year Change
-60.55%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $17.93M, a decrease of -97.90%. That is a compound annual growth rate of -42.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 17.93M | -90.39% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exicure | 18.90M |
| Cellectar Biosciences | 18.16M |
| Lipocine | 18.06M |
| Pasithea Therapeutics | 17.94M |
| NewcelX | 17.81M |
| Passage Bio | 17.07M |
| OSR Holdings | 16.56M |
| HCW Biologics | 15.76M |